Thrombosis, Hypercoagulable States, and Anticoagulants.

Area of Science:

• Hematology
• Vascular Medicine
• Clinical Diagnostics

Background:

• Secondary hemostasis disorders, including inherited or acquired thrombophilias, elevate the risk of venous thromboemboli (VTE).
• Clinical evaluation for suspected VTE relies on evidence-based algorithms incorporating pretest probability assessment.
• Diagnostic pathways may involve D-dimer testing and imaging modalities.

Purpose of the Study:

• To outline the diagnostic approach for patients with suspected venous thromboemboli (VTE).
• To define the appropriate use of hypercoagulable disorder testing in VTE evaluation.
• To identify patient populations for whom direct oral anticoagulants (DOACs) should be avoided.

Main Methods:

• Review of evidence-based algorithms for VTE diagnosis.
• Assessment of clinical criteria for guiding diagnostic work-up.
• Identification of contraindications for direct oral anticoagulant therapy.

Main Results:

• VTE risk is increased in patients with secondary hemostasis derangements.
• Pretest probability calculation from history and physical exam guides VTE work-up.
• Hypercoagulable disorder testing is indicated only in VTE patients with elevated thrombophilia risk.
• Direct oral anticoagulants are first-line VTE treatment but contraindicated in specific conditions.

Conclusions:

• Diagnostic algorithms effectively manage suspected VTE.
• Targeted testing for thrombophilia improves diagnostic yield.
• Careful consideration of patient factors is crucial when prescribing direct oral anticoagulants for VTE.